0 items USD 0.00Search
Your search for "global markets direct pulmonary hypertension pipeline review h2 2014" gave back 83406 results.
Summary Pulmonary Arterial Hypertension (PAH) Medicine market research report provides the newest industry data and industry future trends, allowing...
Catalog:
ICRW
March 2019
Price: USD 2,960.00
The global Pulmonary Hypertension Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Pulmonary...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Primary Pulmonary Hypertension (PPH) Treatment market size was valued at US$ million in 2022. With growing demand in downstream market,...
Catalog:
LPI
December 2023
Price: USD 3,660.00
The “Pulmonary Hypertension Drug Industry Forecast” looks at past sales and reviews total world Pulmonary Hypertension Drug sales in 2022, providing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Pulmonary Arterial Hypertension (PAH) Medicine Industry Forecast” looks at past sales and reviews total world Pulmonary Arterial Hypertension (...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Pulmonary Arterial Hypertension (PAH) Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The “Pulmonary Arterial Hypertension (PAH) Drugs Industry Forecast” looks at past sales and reviews total world Pulmonary Arterial Hypertension (PAH...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Pulmonary Hypertension Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Pulmonary Arterial Hypertension Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The “Pulmonary Arterial Hypertension (PAH) Industry Forecast” looks at past sales and reviews total world Pulmonary Arterial Hypertension (PAH) sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Chronic Pulmonary Hypertension Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Chronic Pulmonary Hypertension Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in...
Catalog:
LPI
February 2023
Price: USD 3,660.00
